Zhai, Linzhu <br/><br/>
Long-term results of pirarubicin versus doxorubicin in combination chemotherapy for aggressive non-Hodgkin's lymphoma: single center, 15-year experience.  [electronic resource] 

 -  International journal of hematology  Jan 2010 
 - 78-86 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1865-3774 
<br/><br/><label>Standard No.: </label>10.1007/s12185-009-0461-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Humans<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Middle Aged<br/>Prednisone--administration & dosage<br/>Remission Induction<br/>Retrospective Studies<br/>Survival Analysis<br/>Treatment Outcome<br/>Vincristine--administration & dosage<br/>Young Adult